A new animal- and cell-free method has been developed to measure the toxic activity of Botulinum neurotoxin (BoNT), e.g. Botox. The invention will avoid the use of mouse LD50 tests for toxicity testing, e.g. in BoNT-containing pharmaceutical products such as Botox.
The method uses functionalized liposomes to determine the toxin’s activity under physiological conditions. A press release about the technology has been published here (article in German).
ETH Zurich is looking for a licensing or collaboration partner for the presented opportunity. If you are interested to learn more about the technology please contact Marjan N. Kraak.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
